We found that in CRC, ZEB2 directly associates with PRMT5, recruits it to the promoter region of E-cadherin, catalyzes the repressive H4R3me2 modification, and finally triggers the transcriptional repression of E-cadherin. Here, ZEB2 is linked to colorectal carcinoma.